Rotella Capital Management’s Fortress Biotech FBIO Stock Holding History

Rotella Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,935	Closed	-$112K	–	473
2015 Q1	$112K	Buy	+1,935	New	+$80.7K	0.09%	356
2014 Q2	–	Sell	-1,374	Closed	-$41K	–	380
2014 Q1	$41K	Buy	+1,374	New	+$53.6K	0.05%	188

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Rotella Capital Management's FBIO Position: Q2 2015 in Review

Rotella Capital Management sold out of Fortress Biotech (FBIO) in Q2 2015, closing a stake of 1,935 shares — an estimated $112K sold.

Rotella Capital Management first reported a position in FBIO in Q1 2014 and held it in 2 quarters. The position peaked at $112K in Q1 2015. 41 funds tracked by Wall St. Rank hold FBIO as of Q2 2015.

Rotella Capital Management reported no remaining Fortress Biotech position as of Q2 2015 after selling out during the quarter.
Rotella Capital Management sold 1,935 Fortress Biotech shares in Q2 2015, an estimated $112K.
Rotella Capital Management first reported a position in Fortress Biotech in Q1 2014 and held it in 2 quarters.
Rotella Capital Management's Fortress Biotech position peaked at $112K in Q1 2015.
41 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2015.

Based on Rotella Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.